Labo Euromedis (XPAR:ALEMG) EBIT : €22.02 Mil (TTM As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Labo Euromedis EBIT?

Labo Euromedis's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2023 was €-5.33 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2023 was €22.02 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Labo Euromedis's annualized ROC % for the quarter that ended in Jun. 2023 was -43.71%. Labo Euromedis's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -61.36%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Labo Euromedis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 602.82%.

Labo Euromedis EBIT Historical Data

The historical data trend for Labo Euromedis's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labo Euromedis EBIT Chart

Labo Euromedis Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-3.03

28.97

2.84

-5.63

22.02

Labo Euromedis Semi-Annual Data
	Jul13	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial															-2.77	-5.84	0.21	-5.33	27.34

Competitive Comparison of Labo Euromedis's EBIT

For the Medical Devices subindustry, Labo Euromedis's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labo Euromedis's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Labo Euromedis's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Labo Euromedis's EV-to-EBIT falls into.

Labo Euromedis EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €22.02 Mil.

Labo Euromedis (XPAR:ALEMG) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Labo Euromedis's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

	ROC % (Q: Jun. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2022 )	+	Invested Capital (Q: Jun. 2023 ))	/ count )
=	-10.21 * ( 1 - -0.16% )	/	( (23.915	+	22.881)	/ 2 )
=	-10.226336	/	23.398
=	-43.71 %

where

	Invested Capital		(Q: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	59.868	-	9.152	-	( 26.801	-	max(0, 9.545	-	51.874	+	26.801	))
=	23.915

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	54.675	-	9.623	-	( 22.171	-	max(0, 9.769	-	46.276	+	22.171	))
=	22.881

Note: The Operating Income data used here is two times the semi-annual (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Labo Euromedis's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2022		Q: Jun. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-10.654	/	( ( (4.324 + max(15.289, 0))	+	(4.729 + max(10.386, 0)) )	/	2 )
=	-10.654	/	( ( 19.613	+	15.115 )	/	2 )
=	-10.654	/	17.364
=	-61.36 %

where Working Capital is:

	Working Capital		(Q: Dec. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(8.846	+	12.591	+	3.394)	-	(9.152	+	0	+	0.39)
=	15.289

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(10.005	+	10.144	+	0.0010000000000048)	-	(9.623	+	0	+	0.141)
=	10.386

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Labo Euromedis's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2023 )
	=	22.015	/	3.652
	=	602.82 %

Labo Euromedis EBIT Related Terms

Thank you for viewing the detailed overview of Labo Euromedis's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Labo Euromedis (XPAR:ALEMG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Labo Euromedis (XPAR:ALEMG) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

61R:Germany

Address

ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290

Website

https://www.euromedis.fr

Euromedis Groupe is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.

Labo Euromedis (XPAR:ALEMG) Headlines

No Headlines